Peter Nilsson

371 – 380 of 858

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/d4f81cfb-cf32-492f-991f-f84f66734b69?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
37
38
39
40
…
86
next »

2016
Mark Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes : The EPIC-InterAct Case-Cohort Study
Forouhi, Nita G. ; Imamura, Fumiaki ; Sharp, Stephen J. ; Koulman, Albert ; Schulze, Matthias B. ; Zheng, Jusheng ; Ye, Zheng ; Sluijs, Ivonne ; Guevara, Marcela and Huerta, José María , et al. (2016) In PLoS Medicine 13(7).
- Contribution to journal › Article
Mark Specific blood pressure targets for patients with diabetic nephropathy?
Grassi, Guido ; Mancia, Giuseppe ^LU and Nilsson, Peter M. ^LU (2016) In Diabetes Care 39. p.228-233
- Contribution to journal › Article
Mark Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension : Obesity and heart failure
Jordan, Jens ; Toplak, Hermann ; Grassi, Guido ; Yumuk, Volkan ; Kotsis, Vasilios ; Engeli, Stefan ; Cuspidi, Cesare ; Nilsson, Peter M. ^LU ; Finer, Nick and Doehner, Wolfram (2016) In Journal of Hypertension 34(9). p.1678-1688
- Contribution to journal › Scientific review
Mark Ny evidens för nyttan av primärpreventiv lipidsänkning
Held, Claes and Nilsson, Peter M. ^LU (2016) In Läkartidningen 113(31-33).
- Contribution to journal › Article
Mark Metabolomic signatures in atherosclerotic disease : What is the potential use?
Nilsson, Peter M. ^LU and Magnusson, Martin ^LU (2016) In Hypertension Research 39(8). p.576-577
- Contribution to journal › Debate/Note/Editorial
Mark Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial : Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials
Kjeldsen, Sverre E ; Lund-Johansen, Per ; Nilsson, Peter M ^LU and Mancia, Giuseppe ^LU (2016) In Hypertension 67(5). p.808-812
- Contribution to journal › Article
Mark Microbiota patterns and risk of cardiometabolic disease - Opportunities for intervention?
Nilsson, Peter M. ^LU (2016) In Arterial Hypertension 20(1). p.1-4
- Contribution to journal › Article
Mark Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
Tasevska, Irina ^LU ; Enhörning, Sofia ^LU ; Christensson, Anders ^LU ; Persson, Margaretha ^LU ; Nilsson, Peter M. ^LU and Melander, Olle ^LU (2016) In American Journal of Nephrology 44(1). p.22-28
- Contribution to journal › Article
Mark A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Scott, Robert A. ; Freitag, Daniel F. ; Li, Li ^LU ; Chu, Audrey Y. ; Surendran, Praveen ; Young, Robin ; Grarup, Niels ; Stancáková, Alena ; Chen, Yuning and Varga, Tibor V. ^LU , et al. (2016) In Science Translational Medicine 8(341).
- Contribution to journal › Article
Mark Cystatin C and risk of diabetes and the metabolic syndrome - Biomarker and genotype association analyses
Magnusson, Martin ^LU ; Molvin, John ^LU ; Engström, Gunnar ^LU ; Svensson, Patrik ^LU ; Persson, Margaretha ^LU ; Christensson, Anders ^LU ; Nilsson, Peter ^LU and Melander, Olle ^LU (2016) In PLoS ONE 11(5).
- Contribution to journal › Article

« previous
1
…
37
38
39
40
…
86
next »